Suzuken: Interim report
Suzuken: Announcements of individual stocks regarding disposal of treasury stock as share-based compensation with transfer restrictions.
Suzuken: Interim report
Suzuken: Internal Control Report - 78th term (April 1, 2023 - March 31, 2024)
Suzuken: Report on corporate governance, June 25, 2024.
Suzuken: Confirmation letter
Suzuken: Securities report - 78th period (April 1, 2023 - March 31, 2024)
Suzuken: Independent Officer Notification Form
Suzuken: Notice of the 78th Annual General Meeting of Shareholders
Suzuken: Matters not described in the issuance document upon notice of convocation of the 78th Annual General Meeting of Shareholders
Suzuken: Notice of Convocation of the 78th Annual General Meeting of Shareholders
Suzuken: Notice regarding the integration of Suzuken Iwate Miyako Branch
Suzuken: Summary of Financial Results for the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)
Suzuken: Suzuken, FRONTEO, and Shionogi Pharmaceutical aim for social implementation of an AI program to support conversational dementia diagnosis through collaboration between 3 companies
Suzuken: Suzuken Group, EPS Holdings, and Bushu Pharmaceutical sign partnership agreement to support entry of unapproved domestic drugs (drug loss items) into the Japanese market
Suzuken: Notice regarding revisions to earnings forecasts
Suzuken: Treasury Stock Purchase Status Report (based on Section 24-6 (1) of the Act)
Suzuken: Notice regarding joint development and dissemination of new healthcare services by Suzuken, Chubu Electric Power Company, and Welby
Suzuken: Notice regarding completion of cancellation of treasury stock
Suzuken: Corporate Governance Report 2024/03/27
No Data